title: Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
authors.forename: A
authors.initials: A
authors.lastname: Hamaad
authors.forename: R C
authors.initials: RC
authors.lastname: Davis
authors.forename: D L
authors.initials: DL
authors.lastname: Connolly
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006338:Heart Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D014463:Ultrasonography; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015251:Epirubicin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D007069:Ifosfamide; D011241:Prednisone